Drugs / MMR (Measles, Mumps, and Rubella)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00806195 Background | Dec 2008 → Mar 2011 | meningitis, meningococcal infection | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMR (Measles, Mumps, and Rubella) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00806195 ↗ |
| Modality | Vaccine | “MMR (Measles, Mumps, and Rubella) Vaccine” NCT00806195 ↗ |